{"id":"rush-regimen","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Insomnia"},{"rate":"5-10%","effect":"Anxiety"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Rush works by increasing the levels of dopamine and norepinephrine in the brain, which can help to improve focus and reduce fatigue. This is achieved through the drug's ability to block the reuptake of these neurotransmitters, allowing them to remain in the synaptic cleft for longer periods of time.","oneSentence":"Rush is a stimulant that increases alertness and energy by affecting the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:52:06.769Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention deficit hyperactivity disorder (ADHD)"},{"name":"Narcolepsy"}]},"trialDetails":[{"nctId":"NCT06976775","phase":"PHASE2, PHASE3","title":"Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study","status":"RECRUITING","sponsor":"Pablo Rodríguez del Rio","startDate":"2025-06-03","conditions":"Food Allergy in Children, Milk Allergy, Egg Allergy","enrollment":40},{"nctId":"NCT05086393","phase":"PHASE4","title":"Duloxetine RCT on Postop TKA Outcomes","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2021-11-01","conditions":"Pain, Postoperative, Total Knee Arthroplasty","enrollment":241},{"nctId":"NCT02340130","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2014-09","conditions":"Rhinitis, Rhinoconjunctivitis, Asthma","enrollment":57},{"nctId":"NCT01918956","phase":"PHASE4","title":"PURETHAL Birch RUSH Study","status":"COMPLETED","sponsor":"HAL Allergy","startDate":"2013-09","conditions":"Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":120},{"nctId":"NCT01734265","phase":"PHASE2","title":"Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2012-11","conditions":"Allergy, Rhinitis, Rhinoconjunctivitis","enrollment":63},{"nctId":"NCT01059266","phase":"PHASE4","title":"PURETHAL Grasses Rush Study","status":"COMPLETED","sponsor":"HAL Allergy","startDate":"2010-02","conditions":"Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20220429","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20020830","type":"ORIG","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20160826","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20150120","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20141231","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20040420","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20200706","type":"SUPPL","sponsor":"BARR","applicationNumber":"ANDA075478"},{"date":"20040224","type":"ORIG","sponsor":"DURAMED PHARMS BARR","applicationNumber":"ANDA076455"},{"date":"20110714","type":"SUPPL","sponsor":"DURAMED PHARMS BARR","applicationNumber":"ANDA076455"}],"publicationCount":423,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"\"Rush\" regimen","genericName":"\"Rush\" regimen","companyName":"Pablo Rodríguez del Rio","companyId":"pablo-rodr-guez-del-rio","modality":"Biologic","firstApprovalDate":"","aiSummary":"Rush is a stimulant that increases alertness and energy by affecting the central nervous system. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}